In this episode, host Alyssa Watson, DVM, talks with Diane Delmain, DVM, DABVP, about her recent Clinician’s Brief article, “Remdesivir & GS-441524 for Treatment of FIP.” Dr. Delmain discusses the relationship between the two drugs, the hurdles veterinarians face in prescribing them, and the FDA’s stance on compounded GS-441524. She also covers the limitations of retrospective data and the risks associated with unregulated products. Plus, Dr. Delmain shares advice for monitoring for adverse effects and long-term care for cats recovering from FIP.
Resources:
- https://www.cliniciansbrief.com/article/remdesivir-gs441524-feline-infectious-peritonitis-treatment
- https://www.simparicatriodvm.com
Contact:
Where To Find Us:
- Website: CliniciansBrief.com/Podcasts
- YouTube: Youtube.com/@clinicians_brief
- Facebook: Facebook.com/CliniciansBrief
- LinkedIn: LinkedIn.com/showcase/CliniciansBrief/
- Instagram: @Clinicians.Brief
- X: @CliniciansBrief
The Team:
- Alyssa Watson, DVM - Host
- Alexis Ussery - Producer & Multimedia Specialist
Fler avsnitt av Clinician's Brief: The Podcast
Visa alla avsnitt av Clinician's Brief: The PodcastClinician's Brief: The Podcast med Clinician's Brief finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
